Overview

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
A comparison of outcomes between use of oral tranexamic acid as compared to oral placebo in the first days after total knee replacement will be made to determine impact on clinical indications and patient reported outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
Campbell Clinic
Treatments:
Tranexamic Acid